Ascentage Pharma Group International (AAPG) Current Assets (2023 - 2024)
Ascentage Pharma Group International (AAPG) has 2 years of Current Assets data on record, last reported at -$159.2 million in Q4 2024.
- For Q4 2024, Current Assets fell 185.28% year-over-year to -$159.2 million; the TTM value through Dec 2023 reached $186.7 million, changed N/A, while the annual FY2024 figure was -$159.2 million, 183.68% down from the prior year.
- Current Assets reached -$159.2 million in Q4 2024 per AAPG's latest filing, down from $186.7 million in the prior quarter.
- Across five years, Current Assets topped out at $186.7 million in Q4 2023 and bottomed at -$159.2 million in Q4 2024.